top of page |
Details of the target gene |
Gene Model of Rodent Parasite |
PY17X_1220300
|
Gene Model P. falciparum ortholog |
PF3D7_0321400
|
Gene product | protein kinase, putative |
Gene product: Alternative name | pPK1, pseudokinase |
top of page |
Details of the genetic modification |
Inducable system used | No |
Additional remarks inducable system |
|
Type of plasmid/construct used | CRISPR/Cas9 construct: integration through double strand break repair |
PlasmoGEM (Sanger) construct/vector used | No |
Modified PlasmoGEM construct/vector used | No
|
Plasmid/construct map |
|
Plasmid/construct sequence |
|
Restriction sites to linearize plasmid |
|
Partial or complete disruption of the gene | Complete |
Additional remarks partial/complete disruption |
|
Selectable marker used to select the mutant parasite | hdhfr |
Promoter of the selectable marker | unknown |
Selection (positive) procedure | pyrimethamine |
Selection (negative) procedure | No |
Additional remarks genetic modification | A CRISPR/Cas9 plasmid (pDC2-Cas9-gRNA-hdhfr, a kind gift from the Wellcome Genome Campus Advanced Course), was digested with BamHI, and then a DNA fragment containing the P. yoelii U6 promoter and its terminator PCR-amplified from P. yoelii gDNA was ligated using an In-Fusion HD cloning kit (Takara Bio Inc., Shiga, Japan), yielding pDC2-cam-Cas9-PyU6-hDHFR. To generate plasmids to knockout the PY17X_1220300 gene locus or to tag the C-terminal end with Myc epitopes, pDC2-cam-Cas9-PyU6-hDHFR was digested with BbsI and ligated with the gRNA component targeting PY17X_1220300. The plasmid was then digested with HpaI and AatII and DNA fragments for the 5’- and 3’-homologous recombination regions of Py17X_1220300 PCR-amplified from P. yoelii gDNA and hDHFR or hDHFR/yFCU expression cassettes PCR-amplified from pDC2-cam-Cas9-PyU6-hDHFR plasmid or p230p-TRAD4-Rand-mCherry plasmid (kind gift from Dr. Soldati), respectively, were ligated using an In-Fusion HD cloning kit, yielding pDC2-Cas9-PyU6-ΔPypPK1 and pDC2-Cas9-PyU6-PypPK1-myc, respectively. The plasmids for transfection were prepared using a HiSpeed Plasmid Midi Kit (Qiagen, Hilden, Germany) |
Additional remarks selection procedure | |
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
Sequence Primer 1 | |
Additional information primer 1 | |
Sequence Primer 2 | |
Additional information primer 2 | |
Sequence Primer 3 | |
Additional information primer 3 | |
Sequence Primer 4 | |
Additional information primer 4 | |
Sequence Primer 5 | |
Additional information primer 5 | |
Sequence Primer 6 | |
Additional information primer 6 | |
|
top of page |